摘要
目的：观察生白术颗粒剂治疗亚临床肝性脑病的疗效。方法：对６６例确诊患者进行分组观察治疗，治疗组３３例给予生白术颗粒剂，对照组３３例给予乳果糖口服液，并观察２组治疗前后症状积分、数字联接试验（ＮＣＴ）、划线试验（ＬＴ）、肝功能、血氨情况。结果：２组患者症状均有所好转，与治疗前比较，差异均有显著性意义（Ｐ＜０．０５）；治疗组改善心烦、失眠等症状优于对照组，２组治疗后比较，差异有显著性意义（Ｐ＜０．０５）；２组治疗后ＮＣＴ、ＬＴ均有明显改善，与治疗前比较，差异均有非常显著性意义（Ｐ＜０．０１）；治疗后肝功能及血氨亦有所改善，但与治疗前比较，差异无显著性意义。结论：生白术颗粒剂治疗亚临床肝性脑病疗效确切。
Objective: To observe the clinical effect of raw Rhizoma Atractylodis Macrocephalae(RAM) for subclinical hepatie en cephalopathy(SHE). Methods: 66 cases were allocated to treatment group(33 cases treated by RAM) and control group(33 cases treated by lactulose oral liquid) . The symptomatic relief was determined by scoring, and NCT, LT, liver function and blood ammonia were observed. Results: The symptoms were alleviated in both groups after treatment(P < 0. 05, as compared with that before treatment) irritability and insomnia were relieved in treatment group( P < 0. 05, as compared with control group). NCT and Li' showed marked improvement after treatment in both groups(P< 0. 01, as compared with those before treatment). The liver function and blood ammonia also improved but without significant difference. Conclusion: RAM possesses definite curative effect for SHE.
出处
《新中医》
CAS
北大核心
2002年第4期16-18,共3页
New Chinese Medicine
